Active follow-up studies present a viable avenue for establishing the burden of adverse drug reactions (ADRs) at the community level for ADRs reported by either patients or health workers.

With limited resources, it is possible to conduct active surveillance of ADRs for malaria patients in the community, with minimal loss to follow-up.

Health service delivery in both the private sector and in rural areas ought to be reviewed and improved so as to optimise therapy, especially in the treatment of malaria in children.